Michelle DeVries has been involved in infection prevention and hospital epidemiology for 30 years spanning community, university, and federal healthcare facilities as well as post acute care settings. She is passionate about raising awareness around vascular access device complications beyond CLABSI and devotes her time to education on this topic with an emphasis on data collection and analysis. She was a reviewer for the 2016 and 2021 INS Infusion Therapy Standards of Practice and is served on the committee as an author for the 2024 Standards. She is a Senior Adjunct Research Fellow with AVATAR — the Alliance for Vascular Access Teaching and Research, past director at large with VACC (Vascular Access Certification Corporation), and in 2024 serves as the President of the Association for Vascular Access (AVA). For the past 20 years she has been the Senior Infection Control Officer for Methodist Hospitals in Gary, Indiana.